News Chart Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
5.48 ^USD	-1.79%		+8.73%	+29.86%

May. 15	Vanda Pharmaceuticals Says Second Phase 3 Study of Tradipitant in Motion Sickness Yields 'Positive' Results	MT
May. 15	Vanda Pharmaceuticals Inc. Reports Positive Results from A Second Phase III Study of Tradipitant in Motion Sickness	CI

7b891c60593afbc.Ti_0KfN0KPS464F0t4UDqO0YWLcFLxHj535-9T9oPuc.GBnDQJ8TeYKOj-Az_v1nnIJAYNxqQk6klg5PklQNaok8TL5Nx0xfkdaIyA~2ffe898de3074d8bfe2a5ad277151dbd